Overview of Tumor Immunotherapy based on Indoleamine 2, 3 Dioxygenase Inhibitors

XiangYu Hao. Overview of Tumor Immunotherapy based on Indoleamine 2, 3 Dioxygenase Inhibitors. In ICBBE 2020: 7th International Conference on Biomedical and Bioinformatics Engineering, Kyoto, Japan, November, 2020. pages 171-175, ACM, 2020. [doi]

Abstract

Abstract is missing.